If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDevelop North Regulatory News (DVNO)

Share Price Information for Develop North (DVNO)

Share Price is delayed by 15 minutes
Get Live Data
75.50    0.00 (0.00%)
Bid:
73.00
Ask:
78.00
Spread: 5.00 (6.849%)
Market Cap: £19.65m
DVNO Live PriceLast checked at - London Stock Exchange

Intraday Develop North Share Chart

General Meeting Result

18 Feb 2026 14:18

RNS Number : 5502T
Develop North PLC
18 February 2026
 

DEVELOP NORTH PLC

(the "Company" or "DVNO" or "Develop North")

 

Result of General Meeting

18 February 2026

 

The Company is pleased to announce that all resolutions put to the General Meeting of the Company held earlier today were duly passed on a poll. Accordingly, the Proposed Investment Objective and Investment Policy has been adopted and the Directors have been granted the authorities set out in the Circular, including the authority to allot and issue up to 368 million Ordinary Shares and/or C Shares in connection with the Initial Issue and the Share Issuance Programme. Defined terms used in this announcement have the meanings given in the Company's circular to Shareholders published on 16 January 2026 (the "Circular").

 

Details of the number of votes cast for, against and withheld in respect of each resolution are set out below and will also be published on the Company's website at www.developnorth.co.uk.

 

Resolution

Votes For

%

Votes Against

%

Votes Total

Votes Withheld

1. Authority to allot Ordinary Shares and/or C Shares in connection with the Initial Issue and the Share Issuance Programme

15,799,780

100%

0

0.00%

15,799,780

0

2. Disapplication of pre-emption rights in connection with the Initial Issue and the Share Issuance Programme

15,799,780

100%

0

0.00%

15,799,780

0

3. Adoption of the Proposed Investment Objective and Investment Policy

15,799,780

100%

0

0.00%

15,799,780

0

4. Additional authority to allot Ordinary Shares

15,799,780

100%

0

0.00%

15,799,780

0

5. Additional disapplication of pre-emption rights

15,799,780

100%

0

0.00%

15,799,780

0

6. Authority to make market purchases of Ordinary Shares following Initial Admission

15,799,780

100%

0

0.00%

15,799,780

0

7. Authority to make market purchases of Ordinary Shares and/or C Shares following any Subsequent Admission

15,799,780

100%

0

0.00%

15,799,780

0

8. Adoption of the New Articles

15,799,780

100%

0

0.00%

15,799,780

0

 

Notes:

1. A "vote withheld" is not a vote in law and has not been counted in the calculation of the proportion of the votes for and against each resolution.

 

The full text of the resolutions is set out in the Notice of General Meeting contained in the Circular.

 

A copy of the resolutions passed at the General Meeting has been submitted to the National Storage Mechanism and will shortly be available for inspection at:https://data.fca.org.uk/#/nsm/nationalstoragemechanism

For further information regarding the Company (Ticker: DVNO) (LEI: 213800EXPWANYN3NEV68) please call:

 

Develop North PLC Ian McElroy

+44 (0) 191 222 0099

 

Tier One Capital Limited (Investment Adviser) Brendan O'Grady

+44 (0) 191 222 0099 

Cavendish Capital Markets Limited (Financial Adviser and Corporate Broker) Robert PeelAndrew WorneOscar Valeur-Adu

+44 (0) 207 220 0500

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMUWASRNNUUAAR
12
Date   Source Headline
7th Dec 20237:00 amRNSExtension of Share Buyback Programme
1st Dec 202312:49 pmRNSTotal Voting Rights
23rd Nov 202311:22 amRNSDividend Declaration
22nd Nov 20235:02 pmRNSTransaction in Own Shares
20th Nov 20237:00 amRNSReplacement: Commencement of Share Buyback Program
13th Nov 20237:00 amRNSCommencement of Share Buyback Programme
9th Nov 202312:56 pmRNSNet Asset Value(s)
30th Aug 20237:00 amRNSDividend Declaration
26th Jul 20237:05 amRNSNet Asset Value(s)
26th Jul 20237:00 amRNSHalf-year Report
31st May 202312:05 pmRNSDividend Declaration
27th Apr 202312:53 pmRNSResult of AGM
27th Apr 202312:49 pmRNSNet Asset Value(s)
30th Mar 20236:29 pmRNSFinal Results
9th Mar 20235:35 pmRNSDividend Declaration
17th Nov 20221:34 pmRNSDividend Declaration
17th Nov 20221:31 pmRNSNet Asset Value(s)
30th Aug 20224:25 pmRNSDividend Declaration
10th Aug 20223:04 pmRNSHalf-year Report
31st May 20223:44 pmRNSDividend Declaration
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.